Friday, January 31, 2020

February 01, 2020 at 12:47AM Oral Immunotherapy

Oral immunotherapy is a medical treatment in which an individual who is allergic to a specific food consumes an increasing amount of the allergen with the goal of reducing the risk of allergic reactions to the food.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2tj0vxZ

January 31, 2020 at 11:12PM FDA approves first drug for treatment of peanut allergy for children

FDA approves first drug for treatment of peanut allergy for children
Treatment with this product may be initiated in individuals ages 4 through 17 years with a confirmed diagnosis of peanut allergy and may be continued in individuals 4 years of age and older.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2uUSJLe

January 31, 2020 at 10:37PM Perspectives on In Vitro Diagnostic Devices Regulated by the Office of Blood Research and Review; Public Workshop - 07/15/2019 - 07/16/2019

The purpose of this workshop is to provide an overview of key elements of regulatory submissions for these devices, and to facilitate education and communication between manufacturers and sponsors of these devices and the divisions in CBER that regulate them.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2J8iE5y

January 31, 2020 at 08:44PM Postapproval Changes to Drug Substances Guidance for Industry

Pharmaceutical Quality/CMC

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/38OHjXN

January 31, 2020 at 07:45PM Licensed Biological Products with Supporting Documents

Licensed biological products with supporting documents is arranged alphabetically by the proper name of the product(s). Information is provided for original product approvals, new indications, and the current package insert.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2mlPLLB

January 31, 2020 at 07:45PM Fluzone High-Dose Quadrivalent

For active immunization of persons 6 months of age and older for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/34vv3JC

January 31, 2020 at 07:37PM Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under section 505 of the Act and biological drugs licensed under section 351 of the Public Health Service Act.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Yc9luW

January 31, 2020 at 07:27PM Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs)

This is the Guidance ,Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs), CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2GwM9ge

January 31, 2020 at 07:24PM Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up

Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up, Guidance, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/312vrPy

January 30, 2020 at 12:00PM CIRAD and INRAE: ongoing pooling of resources on the international stage

On Monday 27 January 2020, CIRAD President Managing Director Michel Eddi and INRAE CEO Philippe Mauguin officially renewed the CIRAD-INRAE Joint Support Unit for International Relations (UMA-RI) for a further four years, and decided to step up global partnerships between the two organizations.



via CIRAD - Actualités / News https://ift.tt/2Oi1Pbs

January 31, 2020 at 12:22PM Santé globale : un dispositif en réseau d’envergure mondiale est nécessaire

Les maladies infectieuses, telles qu’Ebola, les coronavirus ou les maladies vectorielles, sont en expansion en raison des transformations économiques, politiques et sociales accentuées par les bouleversements climatiques et écologiques globaux. Dans ce contexte, le Cirad propose de construire un dispositif en réseau en santé globale d’envergure mondiale. Objectif : améliorer l’utilisation, par les différents acteurs, des résultats issus de la recherche et des recommandations nationales ou internationales. A découvrir dans le dernier numéro de Perspective.



via CIRAD - Actualités / News https://ift.tt/2tgS8mz

January 29, 2020 at 04:21PM DynACof offers quick and open source modelling of agroforestry coffee production

An international team of researchers, coordinated by CIRAD, has developed a modelling tool capable of simulating agroforestry coffee production and its ecosystem services. Parameterized in Costa Rica, the DynACof (Dynamic Agroforestry Coffee) model could help predict the impacts of climate change on plantations and envisage their adaptation through agroforestry. Details of the open source model have just been published in the journal Environmental Modelling and Software .



via CIRAD - Actualités / News https://ift.tt/2uP4UJr

January 30, 2020 at 06:01PM CPG Sec. 270.100 Final Container Labels - Allergenic Extracts Containing Glycerin; Reporting Changes

CPG Sec. 270.100 Final Container Labels - Allergenic Extracts Containing Glycerin; Reporting Changes

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2UaPUQs

January 30, 2020 at 05:57PM CPG 230.120- Human Blood and Blood Products as Drugs

CPG 230.120- Human Blood and Blood Products as Drugs

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2RECgUg

January 30, 2020 at 05:53PM CPG Sec. 230.100 Blood and Blood Products - Definitions

CPG Sec. 230.100 Blood and Blood Products - Definitions

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Sg9OHx

January 30, 2020 at 09:15PM OraQuick Rapid HIV-1 Antibody Test

Allow for a labeling claim for the detection of antibodies to HIV-1 in venipuncture whole blood specimens and to reduce the maximum read time from 60 minutes to 40 minutes.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/318mtjy

January 30, 2020 at 08:29PM OraQuick ADVANCE Rapid HIV-1/2 Antibody Test

Added labeling claim for the detection of HIV-2 antibodies in oral fluid and a change in the name of the device to OraQuick ADVANCE Rapid HIV-1/2 Antibody Test

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2REdVho

January 30, 2020 at 08:16PM NucliSens HIV-1 QT

In conjunction with clinical presentation and other laboratory markers of disease progression for prognostic assessment of HIV-1 infected patients, and for monitoring the effects of anti-retroviral therapy by serial measurements of plasma HIV-1 RNA for pediatric and adult patients with baseline vir

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/38QvjFb

January 30, 2020 at 04:53PM L’expertise du Cirad présente à Fruitlogistica, le plus grand salon mondial des fruits et légumes frais

Acteur incontournable du salon Fruit Logistica, le Cirad présentera son expertise sur un stand original, à Berlin, du 5 au 7 février. Au-delà de tables rondes et réunions stratégiques, l’institution a également programmé des rencontres de haut niveau avec des professionnels et institutionnels des filières fruits et légumes frais. Un rendez-vous à ne pas manquer. Retrouvez le Cirad Hall 25, stand C04.



via CIRAD - Actualités / News https://ift.tt/37I8O5p

January 30, 2020 at 04:53PM L’expertise du Cirad présente à Fruitlogistica, le plus grand salon mondial des fruits et légumes frais

Acteur incontournable du salon Fruit Logistica, le Cirad présentera son expertise sur un stand original, à Berlin, du 5 au 7 février. Au-delà de tables rondes et réunions stratégiques, l’institution a également programmé des rencontres de haut niveau avec des professionnels et institutionnels des filières fruits et légumes frais. Un rendez-vous à ne pas manquer. Retrouvez le Cirad Hall 25, stand C04.



via CIRAD - Actualités / News https://ift.tt/2RFzfmM

January 27, 2020 at 09:37PM Fruit Logistica 2020

The world fruit and vegetable trade fair. With the participation of CIRAD.



via CIRAD - Agenda / Events https://ift.tt/2RE4eiK

January 27, 2020 at 01:53PM Ecology and Evolution of Infectious Diseases Meeting

Co-organized by CIRAD. Four scientific topics will be covered: diversity of host resistance to pathogens, disease control, the crazy life of microbes, and using genomics and immunity to infer pathogen dynamics.



via CIRAD - Agenda / Events https://ift.tt/2GCbg1e

January 27, 2020 at 01:45PM UNESCO Chair in World Food Systems Annual Symposium

Symposium organized with the support of CIRAD, on the topic of food and biodiversity and links within nature. With contributions from CIRAD's Michel Eddi during the opening and Selim Louafi during the closing session.



via CIRAD - Agenda / Events https://ift.tt/37EkxBL

January 30, 2020 at 01:28PM Blood Guidances

This page contains a listing of Blood Guidances guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lznGQ9

January 30, 2020 at 01:19PM Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components; Draft Guidance for Industry

The draft guidance document provides blood establishments that collect blood and blood components with revised recommendations intended to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood components.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2OcZ8bd

January 30, 2020 at 12:00PM Le Cirad et INRAE : une mutualisation à l’international renouvelée

Les Présidents directeurs généraux d’INRAE et du Cirad, Philippe Mauguin et Michel Eddi, ont signé ce lundi 27 janvier 2020 le renouvellement pour 4 ans de l’Unité mixte Cirad-INRAE d’Appui aux Relations Internationales (UMA-RI) et décidé de renforcer les partenariats à l’international entre les deux organismes de recherche.



via CIRAD - Actualités / News https://ift.tt/313Tz4c

Wednesday, January 29, 2020

January 29, 2020 at 11:24PM Ch. 2 - FDA Authority

Ch. 2 - FDA Authority

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3aSd0l1

January 29, 2020 at 10:41PM Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines

Draft Guidance for Industry: Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Zghta9

January 29, 2020 at 10:34PM Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies

Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies Draft Guidance for Industry, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2RY62lW

January 29, 2020 at 08:47PM Section 8000: General Information

This is the main page for CBER's SOPP Section 8000: General Information.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/322hgJI

January 29, 2020 at 08:03PM Postapproval Changes to Drug Substances Guidance for Industry

Pharmaceutical Quality/CMC

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/38OHjXN

January 29, 2020 at 07:50PM Recommended Methods for Blood Grouping Reagents Evaluation

This is the draft guidance for Recommended Methods for Evaluating Potency, Specificity, and Reactivity of Anti-Human Globulin, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/39Q6F9b

January 29, 2020 at 07:48PM Recommended Methods for Evaluating Potency, Specificity, and Reactivity of Anti-Human Globulin

Recommended Methods for Evaluating Potency, Specificity, and Reactivity of Anti-Human Globulin, cber, biologics, blood

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Fv1Wf1

January 29, 2020 at 07:35PM Recommendations for Requalification of Blood Donors Deferred Because of Reactive Test Results for Antibodies to Human T-Lymphotropic Virus Types I and II (anti-HTLV-I/II)

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft document entitled “Recommendations for Requalification of Blood Donors Deferred Because of Reactive Test Results for Antibodies to Human T-Lymphotropic Virus Types I and II (anti-HTLV-I/II.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2RYJ7H9

January 29, 2020 at 07:04PM Testing for Biotin Interference in In Vitro Diagnostic Devices

Testing for Biotin Interference in In Vitro Diagnostic Devices, Draft Guidance for Industry, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2tS7kqC

January 29, 2020 at 04:21PM DynACof : simuler la production de café agroforestier et ses services écosystémiques

Une équipe internationale de chercheurs, coordonnée par le Cirad, a créé un outil de modélisation capable de simuler la production et les services écosystémiques du café agroforestier. Paramétré au Costa Rica, ce modèle, DynACof (Dynamic Agroforestry Coffee), vise à terme à prévoir les impacts des changements climatiques sur les plantations et à imaginer leurs adaptations grâce à l’agroforesterie. Les détails du modèle, accessible en Open source, viennent d’être publiés dans la revue Environmental Modelling and Software .



via CIRAD - Actualités / News https://ift.tt/2O3yGAT

January 29, 2020 at 04:23PM Amendment to "Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry"

This guidance, when finalized, will amend the document entitled “Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry” updated January 2016.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2O6TSFW

January 29, 2020 at 04:13PM Implementation of Pathogen Reduction Technology in the Manufacture of Blood Components in Blood Establishments: Questions and Answers

This is the Draft Guidance for Industry for Implementation of Pathogen Reduction Technology in the Manufacture of Blood Components in Blood Establishments: Questions and Answers.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3aRhtV1

January 29, 2020 at 03:59PM Agriflu

Active immunization of adults 18 years of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3aOwSoZ

January 28, 2020 at 08:06PM June 20, 2016: Blood Products Advisory Committee Meeting Announcement - 06/20/2016 - 06/20/2016

On June 20, 2016, the Blood Products Advisory Committee Meeting members will participate in the meeting via teleconference.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Z8cc4q

January 28, 2020 at 06:09PM Industry Supported Scientific and Educational Activities

Guidance for Industry - Industry Supported Scientific and Educational Activities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/36y2kEE

January 28, 2020 at 06:07PM Computerized Systems Used in Clinical Investigations

Guidance for Industry - Computerized Systems Used in Clinical Investigations, Compliance

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/36xLINw

January 28, 2020 at 03:35PM Multispot HIV-1/HIV-2 Rapid Test

For the detection and differentiation of circulating antibodies associated with HIV-1 and HIV-2 in human plasma and serum, as an aid in the diagnosis of infection with HIV-1 and/or HIV-2

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/37A7Nwa

January 28, 2020 at 03:21PM MedMira Reveal Rapid HIV-1 Antibody Test

Detection of antibodies to HIV-1 in human serum or plasma specimens

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2O4KGlG

January 28, 2020 at 03:20PM R & B Medical Group Inc. - 596508 - 01/15/2020

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2O6Ic6f

January 28, 2020 at 03:09PM MedMira Reveal G2 Rapid HIV-1 Antibody Test

To allow for the addition of a procedural and reagent control line, a change in the packaging of the Colorimetric Detection Agent, and a change in the name of the device to Reveal TM G2 Rapid HIV-1 Antibody Test

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2RZw7kv

January 28, 2020 at 02:29PM FDA Continues Strong Support of Innovation in Development of Gene Therapy Products

FDA Continues Strong Support of Innovation in Development of Gene Therapy Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2RZbEvU

January 28, 2020 at 01:35PM Recently Issued Guidance Documents

This page lists Recently Issued CBER and Cross-Center Guidance Documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2GCffLB

January 28, 2020 at 01:18PM Cellular & Gene Therapy Guidances

This page contains a listing of cellular and gene therapy guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2s8REOH

January 28, 2020 at 01:10PM Human Gene Therapy for Retinal Disorders

Human Gene Therapy for Retinal Disorders, Guidance for Industry, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Rw2OqH

January 28, 2020 at 01:08PM Human Gene Therapy for Rare Diseases

Human Gene Therapy for Rare Diseases, Guidance for Industry, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/36v6BbX

January 28, 2020 at 01:07PM Human Gene Therapy for Hemophilia

Human Gene Therapy for Hemophilia, Draft Guidance for Industry, CBER, biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2uImFty

January 28, 2020 at 01:03PM Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up

Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up, Guidance, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/312vrPy

January 28, 2020 at 12:58PM Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs)

This is the Guidance ,Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs), CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2GwM9ge

January 28, 2020 at 12:53PM Long Term Follow-up After Administration of Human Gene Therapy Products

Long Term Follow-up After Administration of Human Gene Therapy Products, Guidance, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2RP4UAI

Monday, January 27, 2020

January 28, 2020 at 06:27AM Interpreting Sameness of Gene Therapy Products Under the Orphan Drug Regulations

This the draft guidance Interpreting Sameness Gene Therapy Products Orphan Drug Regulations

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2TZKyrc

January 27, 2020 at 09:48PM Isolex 300 & 300i Magnetic Cell Selection System

Processing autologuous peripheral blood progenitor cell (PBPC) products to obtain a CD 34+ cell enriched population intended for hematopoietic reconstitution after myeloablative therapy in patients with CD 34-negative tumors.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2t6jWKi

January 27, 2020 at 09:37PM Salon Fruit Logistica 2020

Rendez-vous mondial du commerce des fruits et légumes. Avec la participation du Cirad.



via CIRAD - Agenda / Events https://ift.tt/3aMVvm5

January 27, 2020 at 06:51PM Vaccines, Blood & Biologics

From blood to vaccines, FDA protects and advances the public health by ensuring that biological products are safe, effective, and available to those who need them. Read these Consumer Updates to learn more.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QQ7hod

January 27, 2020 at 06:46PM Consumer Updates

Get timely, reliable, health and safety information about food, drugs, medical devices, vaccines, pet food, pet medicine and more.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/31VUzHA

January 27, 2020 at 06:33PM Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products

Draft Guidance for Industry: Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/34FNbQK

January 27, 2020 at 06:53PM Drugs

Consumer articles about over-the-counter and prescription drugs.

via Consumer Updates RSS Feed https://ift.tt/2OdHMNL

January 27, 2020 at 06:51PM Vaccines, Blood & Biologics

From blood to vaccines, FDA protects and advances the public health by ensuring that biological products are safe, effective, and available to those who need them. Read these Consumer Updates to learn more.

via Consumer Updates RSS Feed https://ift.tt/2QQ7hod

January 27, 2020 at 05:30PM Antimicrobial Resistance Information from FDA

Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32B6bAj

January 27, 2020 at 05:30PM Medical Countermeasure Monitoring and Assessment

FDA guidance and regulatory information, specific FDA projects related to monitoring and assessment of MCMs, ongoing FDA work related to medical product assessment in general, and key efforts relevant to MCM monitoring and assessment outside of FDA

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LHhwcS

January 27, 2020 at 05:18PM What to Know and Do About Possible Nitrosamines in Your Medication

Concerned that your medications might contain a substance that could potentially cause cancer? Keep taking your medications, and talk to your doctor. FDA is working with manufacturers to investigate the source of nitrosamines in drugs and whether they pose risks to human health. Have questions?

via Consumer Updates RSS Feed https://ift.tt/2tTT1BK

January 23, 2020 at 02:27PM CIRAD and CATIE: more than 30 years of cooperation in Central America focusing on the future of rural populations

For more than 30 years, CIRAD and CATIE have been contributing through their joint projects to improving the quality of life of rural populations in Central America. A partnership based on issues that have become critical for the region – climate change, natural resource management, development linked to cocoa- and coffee-based farming systems. The two institutions have renewed their partnership for ten years within the Mesoamerican Scientific Platform for Agroforestry and are pursuing a number of other projects .



via CIRAD - Actualités / News https://ift.tt/2GpRXrN

January 24, 2020 at 10:09AM CIRAD has relaunched and broadened its scientific partnership with Congo

CIRAD and the Congo Ministry of Research and Innovation recently signed a general cooperation agreement for a renewed partnership centring on research and training. The agreement broadens the existing partnership, which historically centred on forestry development, to cover new fields: agriculture, agrifoods, and human, plant and animal health .



via CIRAD - Actualités / News https://ift.tt/2uzblQA

January 27, 2020 at 01:53PM Colloque Ecology and Evolution of Infectious Diseases

Co-organisé par le Cirad. 4 thèmes scientifiques seront abordés : la diversité de la résistance de l'hôte aux agents pathogènes, la lutte contre les maladies, la vie des microbes, l'utilisation de la génomique et de l'immunité pour déduire la dynamique des agents pathogènes.



via CIRAD - Agenda / Events https://ift.tt/2RWfzd9

January 27, 2020 at 01:45PM Colloque annuel de la Chaire Unesco alimentations du monde

Colloque organisé avec le soutien du Cirad sur le thème Alimentations et biodiversité : se relier dans la nature. Avec l'intervention de Michel Eddi lors de l'ouverture et Selim Louafi en conclusion.



via CIRAD - Agenda / Events https://ift.tt/2t1ppC5

January 22, 2020 at 04:03PM Moonlight disrupts the circadian clock of coffee trees

A study by CIRAD has shown for the first time that despite its very low intensity, moonlight affects coffee trees on a molecular level, and disrupts their circadian clock. It would therefore be in the interests of the horticultural and market garden sectors to control the effect on crops of this type of light. The results of the CIRAD study have just been published in the journal BMC Plant Biology .



via CIRAD - Actualités / News https://ift.tt/2tS9Ywg